Jaid, Baby Boy .

HRN: 28-16-51  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/01/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/01/2025
12/08/2025
IV
37.5 Mg
Q24hrs
MAS
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines